Latest News

Latest News

News from the World Hepatitis Alliance

Webinar on the Global Movement to Eliminate Viral Hepatitis

27 Oct 2015 Bridie Taylor

Learn more about the global movement to eliminate viral hepatitis. On 28 th October WHA President Charles Gore and WHA Executive Board Member for the...

WHO Regional Committee meetings see regions commit to tackling viral hepatitis

23 Oct 2015 Bridie Taylor

Despite viral hepatitis impacting almost every country in the world, the burden differs significantly from region to region. In order to achieve...

Expanding the membership base of the World Hepatitis Alliance

1 Oct 2015 Bridie Taylor

The membership base of the World Hepatitis Alliance continues to go from strength to strength as we welcome five new organisations. Our membership is...

Looking ahead to the next Summit

17 Sep 2015 Bridie Taylor

Following the first World Hepatitis Summit that took place in Glasgow, Scotland 2-4 September, we are already looking ahead to the next Summit. The...

Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025

15 Sep 2015

By Keith Alcorn, Infohep.org Reaching the World Health Organization’s proposed targets for viral hepatitis control by 2030 could require global...

Medicines Patent Pool looks at hepatitis C

14 Sep 2015

By Keith Alcorn, Infohep.org Greg Perry, Executive Director of the Medicines Patent Pool, told delegates at the World Hepatitis Summit in Glasgow...

World Health Organization calls for ambitious global targets for viral hepatitis control

5 Sep 2015

By Keith Alcorn, Infohep.org The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of...

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit

4 Sep 2015 Bridie Taylor

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit Global leaders...

World Hepatitis Summit: New data shows relentless rise in hepatitis deaths

2 Sep 2015

New data shows relentless rise in hepatitis deaths: World leaders meet in Scotland to discuss urgent response and move towards elimination of 7th...

Is the elimination of viral hepatitis on the horizon?

28 Jul 2015 Bridie Taylor

Today marks the fifth official World Hepatitis Day where members of the public and the hepatitis community provide a voice for the 4000 lives lost...

Welcoming new members to the World Hepatitis Alliance

17 Jul 2015 Bridie Taylor

Over the past few months we have welcomed a surge of new members to the World Hepatitis Alliance and we are proud to now have 216 member groups in 80...

2 weeks until World Hepatitis Day!

14 Jul 2015 Bridie Taylor

July 28 is now fast approaching and it’s set to be the biggest World Hepatitis Day yet! But we need your support to ensure we reach as many people as...

Calling for greater commitment to the fight against hepatitis at the World Health Assembly

28 May 2015 Bridie Taylor

The 68th session of the World Health Assembly (WHA68) took place in Geneva from 18th-26th May. On 25th May, the World Hepatitis Alliance was invited...

Supporting the launch of guidelines and policies to address viral hepatitis

1 Apr 2015 Bridie Taylor

WHO Injection Safety policy Every year 1.7 million people are infected with hepatitis B through unsafe injection and 315,000 with hepatitis C. Yet up...

Working closely with WHO to develop a global strategy

1 Apr 2015 Bridie Taylor

WHO Strategic and Technical Advisory Committee for hepatitis (STAC-HEP) meeting, Geneva, Switzerland, 19 – 20 February As part of an expert advisory...

Highlighting the importance of patient advocacy at international conferences

31 Mar 2015 Bridie Taylor

24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Istanbul, Turkey, 12 – 15 March Patient led advocacy is vital in...

Need some inspiration for action? : Initiatives from WHA members

28 Feb 2015 Bridie Taylor

Together our voices are stronger and united we can tackle this global killer! The World Hepatitis Alliance is fortunate enough to be made up of...

WHA in official relations with WHO: What does this mean for you?

28 Feb 2015 Bridie Taylor

Fundamental to our ability to influence global hepatitis policy and bring about real change in the world of hepatitis is our relationship with the...

What is the future for hepatitis treatments? And how we can fund hepatitis programmes?

28 Feb 2015 Bridie Taylor

Discussions around hepatitis are dominated by the pioneering new treatments rapidly transforming the landscape and the ensuing heated discussions...

How does the Alliance really represent hepatitis patients?

28 Feb 2015 Bridie Taylor

The World Hepatitis Alliance prides itself as the true voice of hepatitis patients living all over the world. All our work is overseen by an...

Pages

News from infohep

Diabetes raises the risk of liver damage in people with HIV

21 Sep 2020 Keith Alcorn
Almost half of people with HIV with unexplained liver enzyme elevations or other abnormal liver markers had non-alcoholic steatohepatitis (NASH) and...

Models can help predict liver cancer in people cured of hepatitis C

17 Sep 2020 Liz Highleyman
Three new methods using readily available clinical parameters can help predict who will develop hepatocellular carcinoma (HCC) after achieving...

International registries provide more information about COVID-19 and liver disease

17 Sep 2020 Liz Highleyman
People with advanced liver cirrhosis are more likely to develop severe COVID-19 complications and to die from it, but those who have received liver...

Aldafermin reduces liver fat in phase 2 study

14 Sep 2020 Keith Alcorn
Aldafermin significantly reduced liver fat content and liver damage in a phase 2 study of a 24-week treatment course, Dr Stephen Harrison, Visiting...

Fatty liver disease affects one in four in Europe, study estimates

7 Sep 2020 Keith Alcorn
Non-alcoholic fatty liver disease affects one in four people in the general population in Europe and just over one in twenty people have advanced...

Stopping antivirals may offer a chance for a hepatitis B cure

6 Sep 2020 Liz Highleyman
Discontinuation of long-term nucleoside/nucleotide antiviral treatment for hepatitis B can allow some people to achieve a cure, according to a pair...

Immunotherapy combinations show promise for advanced liver cancer

2 Sep 2020 Liz Highleyman
Three checkpoint inhibitor immunotherapy regimens show promise for people with hepatocellular carcinoma (HCC), the most common type of liver cancer,...

Gilead immune modulator has modest effect on hepatitis B surface antigen

1 Sep 2020 Keith Alcorn
Selgantolimod, a toll-like receptor agonist designed to enhance immune responses to hepatitis B virus, showed only modest effects on hepatitis B...

Bulevirtide shows promise as maintenance therapy for hepatitis D

30 Aug 2020 Liz Highleyman
High-dose bulevirtide (Hepcludex) combined with pegylated interferon alfa-2a (Pegasys) or tenofovir disoproxil fumarate (TDF; Viread) led to...

JNJ-3989 achieves sustained reductions in hepatitis B surface antigen

29 Aug 2020 Keith Alcorn
Johnson & Johnson’s short interfering RNA treatment for hepatitis B resulted in sustained reductions in hepatitis B surface antigen when...